LBI-HTA - Publications - Search - Person: Haute Autorité de Santé (HAS), EUnetHTA
Number of items: 1.

Haute Autorité de Santé (HAS), EUnetHTA and Autoridade Nacional do Medicamento e Productos de Saude (INFARMED), EUnetHTA (2017): Regorafenib indicated as monotherapy for the treatment of adult patients with hepatocellular carcinoma (HCC) who have previously been treated with sorafenib. EUnetHTA report. DSD: Horizon Scanning in Oncology 73.

This list was generated on Wed May 23 01:01:28 2018 CEST.